Avectas is accelerating the future of cell therapy with a flexible, easy-to-integrate delivery platform that manufactures healthier and more functional cells for patients. Excelling at complex editing and challenging cargo delivery, the Avectas non-viral delivery platform ensures the next generation of cell therapies can be realized.
The Solupore non-viral delivery system enables the next generation of cell therapies through unparalleled cell health and superior cell functionality, expanding the possibilities for complex editing and challenging cargo delivery. Easy to integrate into existing GMP processes, Solupore accelerates the translation of life-saving therapies to patients.
Company Details
- Employees
- 37
- Founded
- -
- Address
- Ground Floor Building 10,,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- avectas.com
- HQ
- Dublin, Dublin
Avectas Questions
Avectas's website is avectas.com
Avectas's LinkedIn profile is https://www.linkedin.com/company/avectas
Avectas has
37 employees.
View email and phone details for 37
employees at Avectas.
Avectas's industry is
Biotechnology Research
Avectas's top competitors are
Orbsen Therapeutics Limited,
Onk Therapeutics,
Hitech Health,
Vle Therapeutics,
Apc,
Glycostem Therapeutics,
Nuritas,
Alexion Pharmaceuticals, Inc.,
Inceptor Bio,
Oncomark.
Avectas's categories are Biotechnology Research
Avectas's founding year is 2011
